Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Sanofi”

Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin GlargineCompleted
NCT02273180Phase 3Updated Jan 18, 2018
Sponsor: Sanofi
Type 1 Diabetes Mellitus
United States, France, Germany, Hungary, Japan +3 more
Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 2 Diabetes Mellitus Also Using Insulin GlargineCompleted
NCT02294474Phase 3Updated Jan 18, 2018
Sponsor: Sanofi
Type 2 Diabetes Mellitus
United States, Argentina, Chile, Colombia, Germany +7 more
Prospective Surveillance of Febrile Illness for Dengue-Endemic Areas in AsiaCompleted
NCT01218906N/AUpdated Jan 16, 2018
Sponsor: Sanofi
Dengue Fever · Fever
Indonesia, Malaysia, Philippines, Thailand, Vietnam
Prospective Dengue Seroprevalence Study in 5 to 10 Year-old ChildrenCompleted
NCT01477671N/AUpdated Jan 11, 2018
Sponsor: Sanofi Pasteur, a Sanofi Company
Dengue · Dengue Fever · Dengue Hemorrhagic Fever
India
Study of Investigational Pneumococcal Vaccine in Healthy Adults, Toddlers and InfantsCompleted
NCT01446926Phase 1Updated Jan 10, 2018
Sponsor: Sanofi Pasteur, a Sanofi Company
Pneumonia · Pneumococcal Infections · Streptococcus Pneumoniae Infections
Bangladesh
Strategies to Treat Osteoporosis Following a Fragility FractureCompleted
NCT00512499NAUpdated Jan 9, 2018
Sponsor: Université de Sherbrooke
Osteoporosis · Fractures
Canada
Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Healthy Subjects in VietnamCompleted
NCT02640404Phase 2Updated Jan 8, 2018
Sponsor: Sanofi Pasteur, a Sanofi Company
Meningitis · Meningococcal Meningitis · Meningococcal Infections
Vietnam
Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial CancerCompleted
NCT00258362Phase 2Updated Dec 28, 2017
Sponsor: Masonic Cancer Center, University of Minnesota
Endometrial Cancer
United States
Phase 2 Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast CancerCompleted
NCT00404066Phase 2Updated Dec 22, 2017
Sponsor: George Albert Fisher
Breast Cancer · Metastatic Breast Cancer
United States
Isolated Liver Perfusion With OxaliplatinCompleted
NCT01042691Phase 1Updated Dec 20, 2017
Sponsor: David Bartlett
Unresectable Colorectal Liver Metastases
United States
Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing MicroparticlesCompleted
NCT00908960Phase 2Updated Dec 19, 2017
Sponsor: Beth Israel Deaconess Medical Center
Advanced Pancreatic, Colon, Lung, Gastric and Ovarian Cancer
United States
Comparative Study of Influenza Vaccines in Adults, FLUVACS-year 4Completed
NCT00538512Phase 4Updated Dec 6, 2017
Sponsor: University of Michigan
Influenza
United States
Cabazitaxel vs Abiraterone or Enzalutamide in Patients With Poor Prognosis Metastatic Castration-resistant Prostate CancerUnknown
NCT02254785Phase 2Updated Dec 6, 2017
Sponsor: British Columbia Cancer Agency
Metastatic Castration-Resistant Prostatic Cancer
Australia, Canada
A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous (SC) Administered Alirocumab in Healthy Chinese SubjectsCompleted
NCT02979015Phase 1Updated Dec 5, 2017
Sponsor: Sanofi
Hypercholesterolemia
China
Study of Stem Cell Transplantation for Hematologic Malignancies Using Clofarabine and Busulfan RegimenCompleted
NCT00556452Phase 1, Phase 2Updated Dec 5, 2017
Sponsor: University of Michigan Rogel Cancer Center
Leukemia · Hodgkin Lymphoma · Non-Hodgkin Lymphoma · Multiple Myeloma
United States
Chemoradiation With Oxaliplatin and Fluorouracil (5FU) for Locally Advanced Pancreatic CancerTerminated
NCT00463840Phase 1, Phase 2Updated Dec 5, 2017
Sponsor: NYU Langone Health
Pancreatic Cancer
United States
Clofarabine for Relapsed or Refractory T-Cell or B-Cell Non-Hodgkin Lymphoma (NHL)Completed
NCT00156013Phase 1, Phase 2Updated Nov 29, 2017
Sponsor: Oncology Specialists, S.C.
Lymphoma, B-Cell · Lymphoma, Non-Hodgkin
United States
Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in ToddlersCompleted
NCT01001988Phase 3Updated Nov 29, 2017
Sponsor: Sanofi Pasteur, a Sanofi Company
Encephalitis · Japanese Encephalitis
Philippines, Thailand
Recognizing Osteoporosis and Its Consequences in Quebec (ROCQ) ProgrammeUnknown
NCT00359047NAUpdated Nov 21, 2017
Sponsor: CHU de Quebec-Universite Laval
Osteoporosis
Canada
Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic DermatitisCompleted
NCT02277743Phase 3Updated Nov 21, 2017
Sponsor: Regeneron Pharmaceuticals
Dermatitis, Atopic
United States, Bulgaria, Canada, Denmark, Estonia +5 more
Early Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)Completed
NCT01718353Phase 2Updated Nov 20, 2017
Sponsor: Sanofi
Prostate Cancer Metastatic
United States, Canada
Trial of High-Dose Rifampin in Patients With TBCompleted
NCT01408914Phase 2Updated Nov 20, 2017
Sponsor: Harvard University Faculty of Medicine
Tuberculosis
United States, Peru, United Kingdom
Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade GliomaTerminated
NCT01339039Phase 1Updated Nov 17, 2017
Sponsor: Patrick Y. Wen, MD
High Grade Glioma: Glioblastoma (GBM) · High Grade Glioma: Gliosarcoma · Anaplastic Astrocytoma (AA) · Anaplastic Oligodendroglioma (AO)
United States
Caplacizumab Single and Multiple Dose Study in Healthy Japanese and White Subjects.Completed
NCT03172208Phase 1Updated Nov 14, 2017
Sponsor: Ablynx, a Sanofi company
Healthy Volunteers
United States
A Study of Intravenously or Subcutaneously Administered REGN3500 in Healthy Adult SubjectsCompleted
NCT02958436Phase 1Updated Nov 8, 2017
Sponsor: Regeneron Pharmaceuticals
Healthy Volunteers
Belgium

Previous page Next page